← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 19, 2018Last known activity
Mar 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06819670CollaboratorPhase 2Mar 1, 2025
- NCT03347526CollaboratorPhase 3Apr 19, 2018
Details
- Last known activity
- Mar 1, 2025